Prescription Apps for Cognitive Decline: Now Covered by Health Insurance
A significant shift is underway in how cognitive impairments are addressed: digital health applications are increasingly being recognized by insurance providers and prescribed by doctors. These apps, once dismissed as simple “brain training,” are now becoming a standard part of care for individuals experiencing mild cognitive decline and early stages of dementia.
From “Brain Jogging” to Recognized Therapy
For years, commercially available brain-training apps faced skepticism. While they could improve performance on the specific tasks within the app, it remained unclear whether those benefits translated to real-world improvements. However, applications now designated as Digital Health Applications (DiGA) are different.
Scientific Validation
The German Federal Institute for Drugs and Medical Devices (BfArM) requires clinical trials to validate these applications. NeuroNation MED, for example, demonstrated significant improvements in 288 participants compared to standard care, with users reporting fewer forgotten appointments and better concentration. Memodio, designed specifically for dementia patients, followed in early 2025. Both programs adapt to the user’s performance, adjusting the difficulty of exercises focused on memory, attention, and thinking.
How It Works for Patients
Accessing these apps is straightforward. A doctor or psychotherapist prescribes the app following a diagnosis of mild cognitive impairment. The patient then receives a 16-digit activation code from their insurance provider, granting 90 days of free access, with the possibility of renewal through another prescription. Alternatively, preventative online courses focusing on stress management and cognitive elements are also available with insurance coverage.
The Driving Forces Behind the Change
This development isn’t accidental. As life expectancy increases, so does the number of dementia cases, while access to traditional therapy remains limited. Digital solutions offer an accessible alternative. The need is particularly acute for post-COVID-19 patients experiencing cognitive difficulties, who may have limited other treatment options. These apps provide continuous training, objective progress tracking, and potential for long-term prevention.
Looking Ahead
The future could see further personalization through artificial intelligence. Researchers are also developing more precise digital testing methods. Experts anticipate more approved programs, leading to increased competition and higher quality. The German healthcare system is evolving, shifting from reactive treatment to proactive prevention, and from in-person appointments to smartphone-based solutions. The prescription of an app instead of a pill may become commonplace.
Frequently Asked Questions
What is a DiGA?
A DiGA, or Digitale Gesundheitsanwendung, is a certified digital health application that has been evaluated by the Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) and can be prescribed by a doctor.
Which apps have received DiGA certification?
NeuroNation MED and Memodio are two examples of programs that have received DiGA certification.
How long is access to the app free?
Access to the app is free for 90 days after activation with a code from the insurance provider, with the possibility of renewal through a prescription.
How might the increasing availability of these digital health applications change the way cognitive health is managed in the future?